company background image
BBZA logo

BB Biotech DB:BBZA Stock Report

Last Price

€49.40

Market Cap

€2.7b

7D

-2.0%

1Y

-8.7%

Updated

17 Mar, 2024

Data

Company Financials +

BBZA Stock Overview

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG.

BBZA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health4/6
Dividends3/6

BB Biotech AG Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for BB Biotech
Historical stock prices
Current Share PriceCHF49.40
52 Week HighCHF54.20
52 Week LowCHF36.70
Beta0.84
1 Month Change-3.14%
3 Month Change15.42%
1 Year Change-8.69%
3 Year Change-39.16%
5 Year Change-21.77%
Change since IPO-81.22%

Recent News & Updates

Recent updates

Shareholder Returns

BBZADE Capital MarketsDE Market
7D-2.0%1.4%0.4%
1Y-8.7%20.9%6.7%

Return vs Industry: BBZA underperformed the German Capital Markets industry which returned 20.9% over the past year.

Return vs Market: BBZA underperformed the German Market which returned 6.7% over the past year.

Price Volatility

Is BBZA's price volatile compared to industry and market?
BBZA volatility
BBZA Average Weekly Movement4.4%
Capital Markets Industry Average Movement4.2%
Market Average Movement4.7%
10% most volatile stocks in DE Market10.3%
10% least volatile stocks in DE Market2.5%

Stable Share Price: BBZA has not had significant price volatility in the past 3 months.

Volatility Over Time: BBZA's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199310n/ahttps://www.bbbiotech.ch/en/bb-biotech/

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology.

BB Biotech AG Fundamentals Summary

How do BB Biotech's earnings and revenue compare to its market cap?
BBZA fundamental statistics
Market cap€2.74b
Earnings (TTM)-€214.77m
Revenue (TTM)€36.38k

Over9,999x

P/S Ratio

-12.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BBZA income statement (TTM)
RevenueCHF35.00k
Cost of RevenueCHF0
Gross ProfitCHF35.00k
Other ExpensesCHF206.64m
Earnings-CHF206.61m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 26, 2024

Earnings per share (EPS)-3.77
Gross Margin100.00%
Net Profit Margin-590,305.71%
Debt/Equity Ratio13.1%

How did BBZA perform over the long term?

See historical performance and comparison

Dividends

4.2%

Current Dividend Yield

-53%

Payout Ratio

Does BBZA pay a reliable dividends?

See BBZA dividend history and benchmarks
When do you need to buy BBZA by to receive an upcoming dividend?
BB Biotech dividend dates
Ex Dividend DateMar 25 2024
Dividend Pay DateMar 27 2024
Days until Ex dividend7 days
Days until Dividend pay date9 days

Does BBZA pay a reliable dividends?

See BBZA dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.